Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size

Urology

Volumn 67, Issue 2, 2006, Pages 311-315

  Rodriguez Ortner, Elizabeth ^b   Hayes, Richard B ^b   Weissfeld, Joel ^b   Gelmann, Edward P ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; CYTOSINE; HOMEODOMAIN PROTEIN; NUCLEOTIDE; PROSTATE SPECIFIC ANTIGEN; PROTEIN NKX 3 1; THYMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANAMNESIS; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DNA BINDING; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURIA; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN PHOSPHORYLATION;

GENES, TUMOR SUPPRESSOR; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE; TRANSCRIPTION FACTORS;

EID: 31944432502     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.08.021     Document Type: Article

References (23)

1. R. Bhatia-Gaur, A.A. Donjacour, P.J. Sciavolino Roles for Nkx3.1 in prostate development and cancer Genes Dev 13 1999 966 977
2. H.J. Voeller, M. Augustus, V. Madlike Coding region of NKX3.1, prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers Cancer Res 57 1997 4455 4459
3. E. Asatiani, W.X. Huang, A. Wang Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer Cancer Res 65 2005 1164 1173
4. E.P. Gelmann, D.J. Steadman, J. Ma Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function Cancer Res 62 2002 2654 2659
5. C.A. Podlasek, J.Q. Clemens, W. Bushman Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development J Urol 161 1999 1655 1661
6. S.H. Freestone, P. Marker, O.C. Grace Sonic hedgehog regulates prostatic growth and epithelial differentiation Dev Biol 264 2003 352 362
7. J.N. Chen, M.C. Fishman Zebrafish tinman homolog demarcates the heart field and initiates myocardial differentiation Development 122 1996 3809 3816
8. S.G. Vesey PSA/prostate volume ratio Br J Urol 74 1994 682 683
9. C.G. Roehrborn, S. Sech, J. Montoya Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination Urology 57 2001 1087 1092
10. S. Loeb, M. Han, K.A. Roehl Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography J Urol 173 2005 63 65
11. J.K. Gohagan, D. Levin, P.C. Prorok The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening trial Control Clin Trials 21 suppl 2001 249S 406S
12. R.B. Hayes, D. Reding, W. Kopp Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial Control Clin Trials 21 2000 349S 355S
13. E.P. Gelmann, D. Chia, P.F. Pinsky Relationship of demographic and clinical factors to free and total prostate-specific antigen Urology 58 2001 561 566
14. J.E. McNeal Pathology of benign prostatic hyperplasia insight into etiology Urol Clin North Am 17 1990 477 486
15. J.E. McNeal Origin and evolution of benign prostatic enlargement Invest Urol 15 1978 340 345
16. G.R. Cunha, R.M. Bigsby, P.S. Cooke Stromal-epithelial interactions in adult organs Cell Differ 17 1985 137 148
17. J.E. Oesterling The origin and development of benign prostatic hyperplasia, an age-dependent process J Androl 12 1991 348 355
18. S.J. Berry, D.S. Coffey, P.C. Walsh The development of human benign prostatic hyperplasia with age J Urol 132 1984 474 479
19. J.L.H.R. Bosch, W.C.J. Hop, W.J. Kirkels The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age prevalence and correlation of symptoms with age, prostate volume and residual urine volume Br J Urol 75 1995 622 630
20. H.A. Guess Epidemiology and natural history of benign prostatic hyperplasia Urol Clin North Am 22 1995 247 261
21. A. Engeland, S. Tretli, T. Bjorge Height, body mass index, and prostate cancer a follow-up of 950,000 Norwegian men Br J Cancer 89 2003 1237 1242
22. V.L. Freeman, Y. Liao, R. Durazo-Arvizu Height and risk of fatal prostate cancer findings from the National Health Interview Survey (1986 to 1994) Ann Epidemiol 11 2001 22 27
23. J.A. Carson, R.A. Fillmore, R.J. Schwartz The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor J Biol Chem 275 2000 39061 39072